➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Express Scripts
Moodys
Mallinckrodt
Medtronic

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Suppliers and packages for biologic ingredient: palivizumab

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Suppliers and packages for biologic ingredient: palivizumab

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities
Applicant Tradename Biologic Ingredient Dosage BLA NDA/ANDA Supplier Package Code Package
Medimmune SYNAGIS palivizumab VIAL 103770 BLA MedImmune, LLC 60574-4113-1 1 mL in 1 VIAL, SINGLE-DOSE (60574-4113-1)
Medimmune SYNAGIS palivizumab VIAL 103770 BLA MedImmune, LLC 60574-4114-1 .5 mL in 1 VIAL, SINGLE-DOSE (60574-4114-1)
>Applicant >Tradename >Biologic Ingredient >Dosage >BLA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
Moodys
Dow
Harvard Business School